Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-334-3 | CAS number: -
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
A waiver for further reproductive/developmental toxicity testing is included, based on the information requirements outlined in the ECHA REACH fact sheet of 15/09/2009 (ref: ECHA-09-FS-05-EN) and based on the outcome of the Integrated Testing Strategy (ITS).
In addition to the toxicokinetics assessment, a toxicokinetics study in accordance with OECD417 was performed to determine the absorption, distribution and excretion of radiolabeled Activated Carbon - High Density Skeleton via the intratracheal route. The toxicokinetic testing in rats showed that only very minimal absorption and translocation of AC-HDS to other organs (mainly to tracheobronchal lymph nodes) occurs after intratracheal instillation. No translocation of AC-HDS to reproductive organs was observed as measured by a sensitive method using radiolabeled AC-HDS. The study concluded that no significant systemic absorption and no systemic exposure of reproductive organs occurs after intratracheal exposure to AC-HDS.
As the findings in a limited 1 -year repeated dose toxicity study (Gross and Nau, 1967), indicated that AC-HDS will primarily cause local effects by inhalation, a 90 -day repeated dose toxicity study by inhalation was performed in which special attention was paid to the investigation of the male and female reproductive organs. No effects were oberved on reproductive organs, sperm parameters or oestrus cycle. The results of the ITS indicate lack of systemic absorption via a relevant route of exposure and absence of effects on reproductive organs and function, justifying the waiving of further reproductive/ developmental toxicity testing. The results for AC-HDS are read across to AC-LDS. Therefore, developmental and two-generation reproduction toxicity studies with AC-LDS are waived.
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
Effects on developmental toxicity
Description of key information
No key information
Additional information
A waiver for the screening test for reproductive/developmental toxicity is included, based on the information requirements outlined in the ECHA REACH fact sheet of 15/09/2009 (ref: ECHA-09-FS-05-EN). Based on the results of the toxicokinetics study and the 90 -day inhalation toxicity study as presented above, further reproductive/developmental toxicity studies are waived.
Justification for classification or non-classification
As no information is available for this endpoint, no conclusion on classification can be drawn.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
